Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer

Journal of Pathology

Volumn 228, Issue 4, 2012, Pages 534-543

  Geraets, Daan ^a   Alemany, Laia ^b,c   Guimera, Nuria ^a,b   De Sanjose, Silvia ^b,c   De Koning, Maurits ^a   Molijn, Anco ^a   Jenkins, David ^a   Bosch, Xavier ^b   Quint, Wim ^a  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Carcinogenic; Cervical cancer; High risk; HPV26; HPV30; HPV67; HPV73; HPV82; Human papillomavirus; Oncogenic

Indexed keywords

ARTICLE; CARCINOGENICITY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 30; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 91; HUMAN TISSUE; INVASIVE CERVICAL CARCINOMA; PAPILLOMA VIRUS; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; COMPLICATION; DNA SEQUENCE; GENETICS; MIDDLE AGED; ONSET AGE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; UTERINE CERVIX TUMOR; VIROLOGY; ADOLESCENT; ADULT; AGE; AGED; CONTROLLED STUDY; HISTOPATHOLOGY; MAJOR CLINICAL STUDY; WART VIRUS;

VIRUS DNA;

AGE OF ONSET; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 84871229338     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4065     Document Type: Article

References (35)

1. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048-1056.
2. Kleter B, van Doorn LJ, Ter Schegget J, et al. Novel shortfragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153: 1731-1739.
3. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517.
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
5. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-787.
6. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2011; 13: 377-381.
7. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens - Part B: Biological agents. Lancet Oncol 2009; 10: 321-322.
8. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009; 4: 8.
9. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
10. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337: 76-84.
11. van Doorn LJ, Molijn A, Kleter B, et al. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 2006; 44: 3292-3298.
12. Tavassoeli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: Lyon, 2003.
13. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-3402.
14. Bernard HU, Burk RD, Chen Z, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-79.
15. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30 848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-935.
16. Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy. J Virol 1995; 69: 3074-3083.
17. De Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004; 324: 17-27.
18. Fu L, Van Doorslaer K, Chen Z, et al. Degradation of p53 by human α-papillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One 2010; 5.
19. Mesplede T, Gagnon D, Bergeron-Labrecque F, et al. P53- degradation activity, expression and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J Virol 2011; 86: 94-107.
20. Naeger LK, Goodwin EC, Hwang ES, et al. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein. Cell Growth Differ 1999; 10: 413-422.
21. Hwang ES, Riese DJ, Settleman J, et al. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J Virol 1993; 67: 3720-3729.
22. Dowhanick JJ, McBride AA, Howley PM. Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 1995; 69: 7791-7799.
23. Desaintes C, Demeret C, Goyat S, et al. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J 1997; 16: 504-514.
24. Thomas M, Narayan N, Pim D, et al. Human papillomaviruses, cervical cancer and cell polarity. Oncogene 2008; 27: 7018-7030.
25. Muench P, Hiller T, Probst S, et al. Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes. Virology 2009; 387: 380-387.
26. Klingelhutz AJ, Roman A. Cellular transformation by human papillomaviruses: Lessons learned by comparing high- and low-risk viruses. Virology 2012; 424: 77-98.
27. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79-82.
28. Duensing S, Lee LY, Duensing A, et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 2000; 97: 10002-10007.
29. Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68: 307-313.
30. Coutlee F, Trottier H, Gagnon S, et al. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. J Clin Virol 2009; 45: 96-99.
31. Pim D, Banks L. Interaction of viral oncoproteins with cellular target molecules: Infection with high-risk vs low-risk human papillomaviruses. Acta Pathol Microbiol Immunol Scand 2010; 118: 471-493.
32. McLaughlin-Drubin ME, Munger K. Oncogenic activities of human papillomaviruses. Virus Res 2009; 143: 195-208.
33. Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in five continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-1799.
34. Schiffman M, Khan MJ, Solomon D, et al. A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 2005; 97: 147-150.
35. Castle PE. The evolving definition of carcinogenic human papillomavirus. Infect Agent Cancer 2009; 4: 7.